2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Diphtheria Immunisation: new trials by email Literature Review of Diphtheria Immunisation trials Research Report on Diphtheria Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants Pneumococcal Conjugate Vaccine formulation 1, Pneumococcal Conjugate Vaccine formulation 2, Pneumococcal Conjugate Vaccine formulation 3 - Pneumococcal Immunisation, Diphtheria Immunisation | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 852 | 2020-05-22 | 2025-09-08 |
| Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants Tetanus and Diphtheria Toxoids Adsorbed, Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum hydroxide - Clostridium Difficile Immunisation, Diphtheria | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 399 | 2019-01-24 | 2025-05-21 |
Diphtheria (1) · Tetanus (1) · Whooping Cough (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bordetella Infections (1) · Clostridium Infections (1) · Corynebacterium Infections (1) · Gram-Negative Bacterial Infections (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Tetanus Toxoid (2) · 13-valent pneumococcal vaccine (1) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Chickenpox Vaccine (1) · Engerix-B (1) · Hepatitis B Vaccines (1) · Herpes Zoster Vaccine (1) · Measles-Mumps-Rubella Vaccine (1) · RotaTeq (1) · Rotavirus Vaccines (1) · pentacel (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sanofi Pasteur, a Sanofi Company (1)
United States (2) · Canada (1) · Honduras (1) · Mali (1) · Puerto Rico (1)